Different method in single ANDA [Bioanalytics]

posted by Compliance – India, 2015-02-18 05:30 (3749 d 19:31 ago) – Posting: # 14451
Views: 4,495

Dear Member,

I need your expert advice in following:

"what would be the agency's look out if single ANDA contains two different method for subject sample analysis at two different site (any of the study condition i.e. fast or fed on different method).

Method contains same range but having difference in the extraction process (i.e. SPE Vs. LLE)and mobile phase composition".

please share your expert thoughts on this and help me in such situation.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
22 visitors (0 registered, 22 guests [including 6 identified bots]).
Forum time: 02:02 CEST (Europe/Vienna)

Far better an approximate answer to the right question,
which is often vague, than an exact answer to the wrong question,
which can always be made precise.    John W. Tukey

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5